Bioactive glass
Bioactive glass is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Gluma and Bioactive Glass Desensitizers in Treatment of Dentin Hypersensitivity in Cervical Non-Carious Lesions
Socket Seal Surgery
RCT on Bioactive Glass S53P4 in Diabetic Foot Osteomyelitis in the Forefoot (DFORCT)
Comparative Study of Different Bone Grafts in Accelerating Tooth Movement
Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute
Clinical Trials (8)
Effect of Gluma and Bioactive Glass Desensitizers in Treatment of Dentin Hypersensitivity in Cervical Non-Carious Lesions
Socket Seal Surgery
RCT on Bioactive Glass S53P4 in Diabetic Foot Osteomyelitis in the Forefoot (DFORCT)
Comparative Study of Different Bone Grafts in Accelerating Tooth Movement
Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute
Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts
Dentin Bridge Formation After Indirect Pulp Capping With Bioactive Glass Incorporated in Resin Composite and Its Adhesive in Comparison With Light Cured Calcium Hydroxide
Bioactive Glass and Platelet Rich Fibrin in Intrabony Defects
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8